Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]
- Market Cap ₹ 2,363 Cr.
- Current Price ₹ 732
- High / Low ₹ 1,044 / 528
- Stock P/E 31.2
- Book Value ₹ 263
- Dividend Yield 0.34 %
- ROCE 9.94 %
- ROE 7.35 %
- Face Value ₹ 5.00
Pros
Cons
- Stock is trading at 2.78 times its book value
- Promoter holding is low: 27.2%
- Debtor days have increased from 68.3 to 104 days.
- Working capital days have increased from 40.3 days to 120 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of BSE Allcap BSE Healthcare BSE SmallCap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|
39 | 61 | 455 | 487 | 620 | 697 | |
30 | 42 | 324 | 365 | 475 | 517 | |
Operating Profit | 9 | 19 | 132 | 122 | 144 | 181 |
OPM % | 23% | 31% | 29% | 25% | 23% | 26% |
3 | 2 | 15 | 19 | 17 | 25 | |
Interest | 9 | 9 | 18 | 8 | 16 | 25 |
Depreciation | 6 | 12 | 41 | 54 | 75 | 84 |
Profit before tax | -3 | 0 | 87 | 80 | 70 | 97 |
Tax % | 49% | 180% | 21% | 23% | 19% | |
-5 | -0 | 68 | 62 | 57 | 76 | |
EPS in Rs | -9.53 | -0.14 | 21.78 | 19.78 | 17.60 | 23.43 |
Dividend Payout % | 0% | 0% | 11% | 14% | 14% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 19% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 33% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 7% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 16 | 16 | 16 | 16 |
Reserves | 6 | 6 | 669 | 723 | 794 | 833 |
131 | 102 | 41 | 32 | 160 | 216 | |
44 | 80 | 150 | 137 | 201 | 230 | |
Total Liabilities | 186 | 192 | 875 | 908 | 1,170 | 1,295 |
74 | 131 | 386 | 471 | 647 | 689 | |
CWIP | 20 | 6 | 28 | 25 | 10 | 3 |
Investments | 1 | 1 | 0 | 0 | 0 | 0 |
91 | 55 | 461 | 412 | 513 | 602 | |
Total Assets | 186 | 192 | 875 | 908 | 1,170 | 1,295 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
-23 | 64 | 128 | 76 | 24 | |
-47 | -54 | -241 | -109 | -129 | |
105 | -41 | 176 | -33 | 84 | |
Net Cash Flow | 36 | -31 | 64 | -66 | -20 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Debtor Days | 79 | 84 | 46 | 55 | 104 |
Inventory Days | 21 | 24 | |||
Days Payable | 76 | 100 | |||
Cash Conversion Cycle | 24 | 8 | 46 | 55 | 104 |
Working Capital Days | -69 | -113 | -17 | 17 | 120 |
ROCE % | 7% | 12% | 10% |
Documents
Announcements
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
10h - Krsnaa Diagnostics not classified as Large Corporate under SEBI as of March 31, 2025.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations') In Respect Of Acquisition Of A Total Stake By Wholly Owned Subsidiary Of The Krsnaa Diagnostics Limited.
24 Apr - Krsnaa subsidiary acquires 16% stake in Apulki Healthcare for INR 16,000, a new oncology-cardiology hospital entity.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22 Apr - Scheduled one-on-one investor meeting on April 23, 2025, discussing only public information.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
12 Apr - Disclosure of voting results for managing director appointment.
-
Announcement under Regulation 30 (LODR)-Change in Management
9 Apr - Resignation of Chief Business Officer Mr. Rupesh Dagar.
Annual reports
Concalls
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Oct 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT REC
-
Jun 2022Transcript PPT
-
Mar 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Nov 2021TranscriptPPT
-
Oct 2021Transcript PPT
Business Profile[1]
Krsnaa Diagnostics Limited is one of India’s largest differentiated diagnostic service providers with a Pan-India presence in Radiology and Pathology. It has established a Pan India presence through partnerships with government hospitals and operates a substantial number of CT and MRI centers.